Condensed Interim Statements of Cash Flows - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
|
| Operating activities: | ||||
| Net loss for the period | $ (1,564,196) | $ (7,534,456) | $ (44,319,942) | $ (14,228,570) |
| Items not involving cash: | ||||
| Amortization | 7,300 | 5,371 | 20,766 | 22,485 |
| Stock based compensation | 412,956 | 428,528 | 1,404,364 | 1,151,933 |
| Other share compensation | 66,234 | |||
| Warrant liability-fair value adjustment | (16,887,802) | (4,075,833) | (13,021,129) | (9,928,944) |
| Warrant liability-foreign exchange adjustment | (70,394) | 283,894 | (33,769) | (651,762) |
| Changes in non-cash working capital items: | ||||
| Amounts receivable, prepaid expenses and deposits | 6,497,151 | (444,935) | 6,213,821 | (2,263,365) |
| Accounts payable and accrued liabilities | 40,992 | 250,756 | 5,824,881 | 2,221,239 |
| Cash used in operating activities | (11,563,993) | (11,086,675) | (43,911,008) | (23,610,750) |
| Financing activities: | ||||
| Net proceeds from issuance of common shares and warrants | 2,582,885 | 18,051,242 | 33,957,796 | 26,908,982 |
| Cash provided by financing activities | 2,582,885 | 18,051,242 | 33,957,796 | 26,908,982 |
| Investing Activities: | ||||
| Cost of Patents | (168,690) | (100,867) | (347,646) | (197,906) |
| Cash used in investing activities | (168,690) | (100,867) | (347,646) | (197,906) |
| Increase (Decrease) in cash and cash equivalents | (9,149,798) | 6,863,700 | (10,300,858) | 3,100,326 |
| Cash and cash equivalents, beginning of the period | 10,320,183 | 22,367,119 | 11,471,243 | 26,130,493 |
| Cash and cash equivalents, end of the period | 1,170,385 | 29,230,819 | 1,170,385 | 29,230,819 |
| Cash and cash equivalents comprise: | ||||
| Cash | 499,637 | 261,935 | 499,637 | 261,935 |
| Cash Equivalents | 670,748 | 28,968,884 | 670,748 | 28,968,884 |
| Cash and cash equivalents, end of the period | $ 1,170,385 | $ 29,230,819 | $ 1,170,385 | $ 29,230,819 |
| X | ||||||||||
- Definition Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of cash on hand and demand deposits. [Refer: Cash on hand] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) in cash and cash equivalents. [Refer: Cash and cash equivalents] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Adjustments for decrease increase in trade account receivable prepaid expenses and deposits No definition available.
|
| X | ||||||||||
- Definition Adjustments for increase decrease in trade payables and accrued liabilities No definition available.
|
| X | ||||||||||
- Definition Adjustments for other share-based payments. No definition available.
|
| X | ||||||||||
- Definition Gains (losses) on fair value adjustment, warrant liability. No definition available.
|
| X | ||||||||||
- Definition Gains (losses) on foreign exchange adjustment, warrant liability. No definition available.
|
| X | ||||||||||
- Definition Increase decrease in working capital. No definition available.
|